A bipartisan bill reintroduced by three senators aims to increase transparency around foreign influence on the United States’ drug supplies as a potential first step to imposing restrictions. | A bipartisan bill reintroduced by three senators aims to increase transparency around foreign influence on the United States’ drug supplies, marking a potential first step to imposing restrictions.

In an initiative to increase the efficiency of drug manufacturing in the United States, the FDA has

Lawmakers want more transparency around foreign influence in the sector, saying there’s no reason to allow rival to control supply chain.

A bipartisan bill reintroduced by three senators aims to increase transparency around foreign influence on the United States’ drug supplies as a potential first step to imposing…